相关实验视频
Updated: Jul 28, 2026
13:06
In Ovo Electroporations of HH Stage 10 Chicken Embryos
Published on: November 1, 2007
18.3K
利用胚胎研究人类增强剂
1University of Manchester, Faculty of Biology, Medicine and Health, Michael Smith Building, Oxford Road, Manchester, United Kingdom.
Developmental biology
|May 14, 2025
概括
胚胎提供了一个可访问的体内模型来研究人类基因调节网络和增强功能. 这种方法有助于验证增强器预测,并了解它们在人类疾病中的作用.
科学领域:
- 遗传学 遗传学 是一个
- 发展生物学 发展生物学
- 基因组学就是基因组学.
背景情况:
- 基因调控网络控制细胞功能和细胞身份.
- 转录增强剂位于非编码基因组中,调节基因表达.
- 增强剂中的致病变体可以导致人类疾病,这对与异常活性相关的关联构成了挑战.
研究的目的:
- 探索使用胚胎在人体增强剂活性体内验证的优势.
- 审查使用胚胎研究增强器功能的进展.
- 讨论与增强剂变种相关的人类疾病理解的影响.
主要方法:
- 利用表观基因组数据来识别假定的组织特异性增强剂.
- 使用胚胎作为体内模型进行增强剂活性评估.
- 利用早期小和人类胚胎发生的相似之处.
主要成果:
- 胚胎为研究人类增强剂序列提供了一个可访问和有效的体内系统.
- 最近的进展有助于在发展背景下阐明增强剂活性.
- 该模型有助于从表观基因组数据中验证预测的增强剂.
结论:
- 胚胎是人类增强器功能的体内验证的一个有价值的模型.
- 了解胚胎发育中的增强剂活性对于疾病基因发现至关重要.
- 这项研究强调了鸟类模型在人类疾病研究中的潜力.
相关概念视频
01:59CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...